Inmed Pharmaceuticals Inc. · NASDAQ:INM

ADAR1 Capital Management, LLC bought 10,903 Inmed Pharmaceuticals Inc. shares (Form 4)

Traded Oct 6 to Oct 8, 2026 · Filed Oct 8, 2026

From Oct 6 to Oct 8, 2026, ADAR1 Capital Management, LLC (10% owner) bought 10,903 Inmed Pharmaceuticals Inc. shares at an average US$1.33 for US$14,484, leaving 945,924 shares. Filed Oct 8, 2026 (Form 4).

Bought: 10,903 shares
Price: US$1.33 average (US$1.33 to US$1.33)
Value: US$14,484
Holding after: 945,924 shares (held indirectly)
Trading plan: No
Role: 10% owner

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 6, 2026	Common Shares	Buy	5,601	US$1.33	940,622	Indirect
Oct 7, 2026	Common Shares	Buy	3,046	US$1.33	943,668	Indirect
Oct 8, 2026	Common Shares	Buy	2,256	US$1.33	945,924	Indirect

Source

View original at SEC

Related